“…In this respect, some studies have previously evaluated the activity of natural and synthetic peptides, including defensins, plectasins, temporins and cathelicidins, against multiple respiratory viruses, such as influenza A virus H5N1, H1N1, MERS-CoV, and SARS-CoV [ 27 , 28 , 29 , 39 , 40 , 57 ]. Similar to this study, in silico analyses showed the potent antiviral effects of AMPs against Betacoronavirus [ 27 , 39 ]. According to our results, the AMPs are attractive candidates as alternative to conventional antiviral drugs to control SARS-CoV-2 infection, because they offer several potential advantages, including specific anti-CoV effects, high selectivity, and do not be associated with severe adverse effects according to in vitro and in vivo assays [ 58 , 59 , 60 ].…”